Lactulose 10 g / 15 ml Oral Solution Sachets

  • Name:

    Lactulose 10 g / 15 ml Oral Solution Sachets

  • Company:
    info
  • Active Ingredients:

    Lactulose

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/08/15

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 1/5/2017
print

Print ViewKeyword Search SPC

Intrapharm Laboratories Limited

Intrapharm Laboratories Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Lactulose 10 g / 15 ml Oral Solution Sachets Active Ingredients Lactulose
Medicine Name Mydrilate 0.5% w/v Eye Drops Active Ingredients Cyclopentolate Hydrochloride
Medicine Name Mydrilate 1.0% w/v Eye Drops Active Ingredients Cyclopentolate Hydrochloride
Medicine Name Nitrolingual Pumpspray 400 micrograms per metered dose, sublingual spray Active Ingredients Glyceryl Trinitrate
Medicine Name Prialt solution for infusion Active Ingredients Ziconotide acetate
1 - 0 of 5 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 1 May 2017 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Finished product shelf-life extended from 2 to 3 years. Type IB MRP variation approved 12Jan2017 (adopted nationally 19Jan2017).

Updated on 1 May 2017

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 7 August 2015 SPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

SmPC changes reflect national approval for the MRP renewal as issued by HPRA 24Jul2015.

Updated on 4 August 2015 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
  • Change to product name
  • Addition of information on reporting a side effect.

Updated on 4 August 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 11 November 2013 SPC

Reasons for updating

  • New SPC for new product

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided

Updated on 7 November 2013 PIL

Reasons for updating

  • New PIL for new product